A CoMFA study of dopamine D2 receptor agonists and x-ray crystal structure of quinelorane dihydrochloride dihydrate, R(-)-apomorphine hydrochloride and R(-)-N-n-propylnorapomorphine hydrochloride

Structural Chemistry

Volumn 15, Issue 6, 2004, Pages 553-565

  Zhu, Naijue ^a   Liang, Li ^a   Klein Stevens, Cheryl L ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

Apomorphine; COMFA; Dopamine agonists; Propylnorapomorphine; Quinelorane; X ray crystallography

Indexed keywords

APOMORPHINE; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; FUNCTIONAL GROUP; NITROGEN; PIPERIDINE; PROPYLNORAPOMORPHINE; QUINELORANE; RECEPTOR;

AGONIST; ARTICLE; CLASSIS; COLOR; COMPARATIVE MOLECULAR FIELD ANALYSIS; CRYSTAL; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG STRUCTURE; ELECTRICITY; HYDROGEN BOND; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STEREOCHEMISTRY; STEREOISOMERISM; THREE DIMENSIONAL IMAGING; X RAY; X RAY CRYSTALLOGRAPHY;

EID: 13744264166     PISSN: 10400400     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11224-004-0730-3     Document Type: Article

References (27)

1. F. Stratta A. Bonci P. Calabresi A. Stefani A. Pisani N. B. Mercuri 1995 Bernardi J. Neural Transm. 45 Suppl. 47 55 G. Stratta, F.; Bonci, A.; Calabresi, P.; Stefani, A.; Pisani, A.; Bernardi, G.; Mercuri, N. B. J. Neural Transm. 1995, 45(Suppl.), 47–55.
2. D. R. Sibley F. J. Monsma Y. Shen 1993 Int. Rev. Neurobiol. 35 391 415 Sibley, D. R.; Monsma, F. J.; Shen, Y. Int. Rev. Neurobiol. 1993, 35, 391–415.
3. C. L. Klein J. M. Conrad 1986 Acta Crystallogr. C42 1083 1085 Klein, C. L.; Conrad, J. M. Acta Crystallogr. 1986, C42, 1083–1085.
4. C. L. Klein L. C. Southall J. Welch 1989 Acta Crystallogr. C45 650 653 Klein, C. L.; Southall, L. C.; Welch, J. Acta Crystallogr. 1989, C45, 650–653.
5. C. L. Klein T. A. Banks D. Rouselle 1991 Acta Crystallogr. C47 1478 1480 Klein, C. L.; Banks, T. A.; Rouselle, D. Acta Crystallogr. 1991, C47, 1478–1480.
6. C. L. Klein J. Lear S. O’Rourke S. Williams L. Liang 1994 J. Pharm. Sci. 83 9 1253 1256 Klein, C. L.; Lear, J.; O’Rourke, S.; Williams, S.; Liang, L. J. Pharm. Sci. 1994, 83(9), 1253–1256.
7. L. Liang N. Zhu J. White C. Brown C. L. Klein Stevens 1998 J. Pharm. Sci. 87 12 1496 1501 Liang, L.; Zhu, N.; White, J.; Brown, C.; Klein Stevens, C. L. J. Pharm. Sci. 1998, 87(12), 1496–1501.
8. N. Zhu L. Johnson J. White C. L. Klein Stevens 2002 Struct. Chem. 13 5/6 491 499 Zhu, N.; Johnson, L.; White, J.; Klein Stevens, C. L. Struct. Chem. 2002, 13(5/6), 491–499.
9. X. Song A. M. Crider S. F. Cruse D. Ghosh C. Klein-Stevens L. Liang M. A. Scheideler A. Varming I. Stofte 1999 Eur. J. Med. Chem. 34 487 503 Song, X.; Crider, A. M.; Cruse, S. F.; Ghosh, D.; Klein-Stevens, C.; Liang, L.; Scheideler, M. A.; Varming, A.; Stofte, I. Eur. J. Med. Chem. 1999, 34, 487–503.
10. R. D. Cramer III D. E. Patterson J. D. Bunce 1988 J. Am. Chem. Soc. 110 5959 5967 Cramer, R. D., III; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959–5967.
11. M.-Y. K. Brusniak R. S. Pearlman K. A. Neve R. E. Wilcox 1996 J. Med. Chem. 39 850 859 Brusniak, M.-Y. K.; Pearlman, R. S.; Neve, K. A.; Wilcox, R. E. J. Med. Chem. 1996, 39, 850–859.
12. R. E. Wilcox T. Tseng M.-Y. K. Brusniak B. Ginsburg R. S. Pearlman M. Teeter C. DuRand S. Starr K. A. Neve 1998 J. Med. Chem. 41 4385 4399 Wilcox, R. E.; Tseng, T.; Brusniak, M.-Y. K.; Ginsburg, B.; Pearlman, R. S.; Teeter, M.; DuRand, C.; Starr, S.; Neve, K. A. J. Med. Chem. 1998, 41, 4385–4399.
13. R. H. Mach P. S. Hammond Y. Huang B. Yang Y. Xu J. T. Cheney R. Freeman R. R. Luedtke 1999 Med. Chem. Res. 9 6 355 373 Mach, R. H.; Hammond, P. S.; Huang, Y.; Yang, B.; Xu, Y.; Cheney, J. T.; Freeman, R.; Luedtke, R. R. Med. Chem. Res. 1999, 9(6), 355–373.
14. G. B. McGaughey R. E. Mewshaw 1999 Bioorg. Med. Chem. 7 2453 2456 McGaughey, G. B.; Mewshaw, R. E. Bioorg. Med. Chem. 1999, 7, 2453–2456.
15. M. J. Eaton K. J. Lookinland K. E. Moore 1994 J. Pharmacol. Exp. Ther. 268 645 652 Eaton, M. J.; Lookinland, K. J.; Moore, K. E. J. Pharmacol. Exp. Ther. 1994, 268, 645–652.
16. D. Bravi T. L. Davis M. M. Mouradian T. N. Chase 1993 Mov. Discord. 2 195 197 Bravi, D.; Davis, T. L.; Mouradian, M. M.; Chase, T. N. Mov. Discord. 1993, 2, 195–197.
17. S. Gancher 1995 J. Neural Transm. 45 Suppl. 137 141 Gancher, S. J. Neural Transm. 1995, 45(Suppl.), 137–141.
18. M. Titeler P. Seeman 1979 Eur. J. Pharmacol. 56 3 291 292 Titeler, M.; Seeman, P. Eur. J. Pharmacol. 1979, 56(3), 291–292.
19. Main, P.; Fiske, S. J.; Hull, S. E.; Lessinger, L.; Germain, G.; Declercq, J.-P.; Woolfson, M. M. MULTAN11/82. A System of Computer Programs for the Automatic Solution of Crystal Structures from X-ray Diffraction Data ; University of York: England and Louvain, Belgium.
20. MolEN, Structure Determination System of programs used for the processing, solving, and interpretation of the data was written by C. K. Fair, 1990.
21. International Tables for X-ray Crystallography ; Kynoch Press: Birmingham, England, 1974; Vol. IV, pp. 71–151.
22. SYBYL Molecular Modeling Software, Version 6.8; Tripos Associates Inc.: St. Louis, MO.
23. P. Seeman H. B. Niznik 1988 ISI Atlas of Science—Pharmacology 2 161 170 Seeman, P.; Niznik, H. B. ISI Atlas of Science—Pharmacology, 1988, 2, 161–170.
24. J. Giesecke 1973 Acta Crystallogr. B29 1785 1791 Giesecke, J. Acta Crystallogr. 1973, B29, 1785–1791.
25. N. Camerman L. Y. Y. Chan A. Camerman 1979 Mol. Pharmacol. 16 729 736 Camerman, N.; Chan, L. Y. Y.; Camerman, A. Mol. Pharmacol. 1979, 16, 729–736.
26. R. Bergin D. Carlstrom 1968 Acta Crystallogr. B24 229 313 Bergin, R.; Carlstrom, D. Acta Crystallogr. 1968, B24, 229–313.
27. P. Seeman M. Watanabe D. Grigoriadis J. L. Tedesco S. R. George U. Svensson J. L. G. Nilsson J. L. Neumeyer 1985 Mol. Pharmacol. 28 391 399 Seeman, P.; Watanabe, M.; Grigoriadis, D.; Tedesco, J. L.; George, S. R.; Svensson, U.; Nilsson, J. L. G.; Neumeyer, J. L. Mol. Pharmacol. 1985, 28, 391–399.